OTC Regs May Hit Buy-Siders Harder
New regulations governing over-the-counter derivatives in the Dodd-Frank Act may hit buy-side participants’ harder than their sell-side counterparts, according to Celent.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
